Crows View

Updated : Jan 20, 2017

Capping stent prices

The National Pharmaceutical Pricing Authority (NPPA) is seriously trying to regulate prices of stents to bring down angioplasty costs.

Updated : Dec 1, 2015

India's organised diagnostics industry is moving to the next level, as Dr Lal PathLabs, one of the oldest and largest in the industry, will tap the capital markets soon with an initial public offer (IPO).

Updated : Nov 26, 2015

Rest in peace, Ranbaxy

Soon Ranbaxy Laboratories will cease to exist as the company is merging with Sun Pharmaceutical Industries.

Updated : Apr 24, 2015

Designer babies may be a turning point in science, but should we take that turn?

The issue is not the scientific innovation that may help many parents to have their next generations devoid of diseases, but the ethical issue of scientific interventions in the sanctity of birth, and sanctity of the phrase 'biological parents'.

Crows View

Capping stent prices

Pathological 'issues'

Rest in peace, Ranbaxy

Designer babies may be a turning point in science, but should we take that turn?

HOT STOCKS

TOP VIDEOS